Sort
48,018 grants matching “immunotherapy”
Hijacking the T cell machinery for logic-gated CAR T cell control
$1,068,000Robbie G. Majzner · Dana-Farber Cancer Inst · DP2 · FY2024 · CA
Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery
$1,068,000Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2021 · CA
05 Tissue Biospecimen and Pathology Resource
$1,067,922Ignacio I. Wistuba · University Of Tx Md Anderson Can Ctr · P30 · FY2025 · CA
Insights from Asian Populations into Disparities in Breast Cancer Prognosis and Outcomes
$1,067,902Scarlett L Gomez · University Of California, San Francisco · R01 · FY2021 · CA
Molecular Allergy
$1,067,574Geoffrey Mueller · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
Local Tumoral Delivered Immune Checkpoint Blockades Immunotherapy and Radioembolization Combination Therapy
$1,067,455Dong-Hyun Kim · Northwestern University At Chicago · R01 · FY2025 · CA
First-in-Class CD206 Agonist for Immunologically Cold Solid Organ Cancers
$1,066,904Sharie Haugabook · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
SPORE in Gastrointestinal Cancer
$1,066,666Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2009 · CA
SPORE in Gastrointestinal Cancer
$1,066,666Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2010 · CA
SPORE in Gastrointestinal Cancer
$1,066,666Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2008 · CA
SPORE in Gastrointestinal Cancer
$1,066,666Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2012 · CA
Activation of Human Natural Killer Cell Function
$1,066,211Eric O Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Targeting Pediatric Cancer Vulnerabilities
$1,066,178Kimberly Stegmaier · Dana-Farber Cancer Inst · R35 · FY2023 · CA
Administrative Core for SWOG SDMC
$1,065,983Michael Leo Leblanc · Fred Hutchinson Cancer Center · U10 · FY2022 · CA
Development of botulinum neurotoxin immunotherapy
$1,065,728University Of California San Francisco · U01 · FY2005 · AI
Integrating targeted and immunotherapy to treat genetically heterogeneous cancers
$1,065,613William A Weiss · University Of California, San Francisco · U01 · FY2017 · CA
Targeting Pediatric Cancer Vulnerabilities
$1,065,492Kimberly Stegmaier · Dana-Farber Cancer Inst · R35 · FY2025 · CA
Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure
$1,065,423Sharon Riddler · University Of Pittsburgh At Pittsburgh · U01 · FY2017 · AI
RNAi Screening in Hematopoietic Cells
$1,065,285Iain Fraser · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Humanized Mouse Avatars for T1D
$1,064,644Dale L Greiner · Univ Of Massachusetts Med Sch Worcester · U01 · FY2019 · DK
New Approaches To Passive Immunoprophylaxis
$1,064,532Robert H. Purcell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Profiling cancer neoantigen repertoires and validating immunotherapy targets
$1,064,486Martin W McIntosh · Fred Hutchinson Cancer Research Center · U01 · FY2016 · CA
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
$1,064,245Douglas F Nixon · Feinstein Institute For Medical Research · R01 · FY2025 · CA
SRC ON PRIMARY AND METASTATIC TUMORS OF THE CNS
$1,063,812Duke University · P50 · FY2000 · NS
Investigating Correlates and Therapeutics of Fatigue in Cancer Patients
$1,063,153Leorey Saligan · National Institute Of Nursing Research · ZIA · FY2017 · NR